Altered levels of cytokines and inflammatory mediators in plasma and leukocytes of sickle cell anemia patients and effects of hydroxyurea therapy.
about
Biomarkers and recent advances in the management and therapy of sickle cell diseaseMechanisms of sickle cell alloimmunizationInformation exploration system for sickle cell disease and repurposing of hydroxyfasudilMethyl-hydroxylamine as an efficacious antibacterial agent that targets the ribonucleotide reductase enzymeInflammation in Sickle Cell Disease: Differential and Down-Expressed Plasma Levels of Annexin A1 ProteinStatins protect against fulminant pneumococcal infection and cytolysin toxicity in a mouse model of sickle cell diseaseHydroxyurea and a cGMP-amplifying agent have immediate benefits on acute vaso-occlusive events in sickle cell disease miceHemin controls T cell polarization in sickle cell alloimmunization.TNF-α, IFN-γ, IL-10, and IL-4 levels were elevated in a murine model of human sickle cell anemia maintained on a high protein/calorie diet.Aggregation of mononuclear and red blood cells through an {alpha}4{beta}1-Lu/basal cell adhesion molecule interaction in sickle cell diseaseParticipation of Mac-1, LFA-1 and VLA-4 integrins in the in vitro adhesion of sickle cell disease neutrophils to endothelial layers, and reversal of adhesion by simvastatinVasculopathy in sickle cell disease: Biology, pathophysiology, genetics, translational medicine, and new research directionsLow bone mass density is associated with hemolysis in Brazilian patients with sickle cell disease.Antitumor mechanisms of amino Acid hydroxyurea derivatives in the metastatic colon cancer model.Methaemalbumin formation in sickle cell disease: effect on oxidative protein modification and HO-1 induction.Role of innate immunity-triggered pathways in the pathogenesis of Sickle Cell Disease: a meta-analysis of gene expression studiesNitric Oxide-cGMP Signaling Stimulates Erythropoiesis through Multiple Lineage-Specific Transcription Factors: Clinical Implications and a Novel Target for Erythropoiesis.The sickle cell mouse lung: proinflammatory and primed for allergic inflammation.Cordycepin induces cell cycle arrest and apoptosis by inducing DNA damage and up-regulation of p53 in Leukemia cells.Impairment of neutrophil oxidative burst in children with sickle cell disease is associated with heme oxygenase-1.Inflammatory targets of therapy in sickle cell disease.Haptoglobin gene polymorphisms and interleukin-6 and -8 levels in patients with sickle cell anemia.Prevention of conversion to abnormal transcranial Doppler with hydroxyurea in sickle cell anemia: A Phase III international randomized clinical trial.Patients with sickle cell disease have increased sensitivity to cold and heat.Neutrophils, platelets, and inflammatory pathways at the nexus of sickle cell disease pathophysiology.Erythrocyte NADPH oxidase activity modulated by Rac GTPases, PKC, and plasma cytokines contributes to oxidative stress in sickle cell disease.Impact of iron overload on interleukin-10 levels, biochemical parameters and oxidative stress in patients with sickle cell anemiaSickle cell vaso-occlusive crisis: it's a gut feeling.Influence of βS-globin haplotypes and hydroxyurea on tumor necrosis factor-alpha levels in sickle cell anemia.The paradox of the neutrophil's role in tissue injury.Emerging point-of-care technologies for sickle cell disease screening and monitoring.Placental growth factor: What hematologists need to know.Alteration of lymphocyte phenotype and function in sickle cell anemia: Implications for vaccine responses.Red cell DAMPs and inflammation.Clinical phenotypes and the biological parameters of Congolese patients suffering from sickle cell anemia: A first report from Central Africa.Abnormal expression of inflammatory genes in placentas of women with sickle cell anemia and sickle hemoglobin C disease.Elevated plasma levels and platelet-associated expression of the pro-thrombotic and pro-inflammatory protein, TNFSF14 (LIGHT), in sickle cell disease.Tricuspid regurgitant velocity elevation in a three-year old child with sickle cell anemia and recurrent acute chest syndromes reversed not by hydroxyurea but by bone marrow transplantation.Plasma eicosanoid profiles determined by high-performance liquid chromatography coupled with tandem mass spectrometry in stimulated peripheral blood from healthy individuals and sickle cell anemia patients in treatment.Tartrate-Resistant Acid Phosphatase 5b in Young Patients With Sickle Cell Disease and Trait Siblings: Relation to Vasculopathy and Bone Mineral Density.
P2860
Q28082462-07432E7E-79CC-49F3-A1C3-8579F641E14CQ28083189-FCF234C1-06F5-4A4C-AD79-B862630C3133Q28533770-B8F92259-B001-4778-A520-8158667F8AF6Q28544447-739F040A-2328-4757-9D9B-FC02740AAAD0Q28553088-9020EE00-9454-4B19-B515-8F458A69EF1CQ30492867-DB81EC05-B30E-4F29-9C74-9B06FE658F4CQ30525565-0DB5FCD9-C639-4576-B3A9-5B8F18B7C1F2Q33797355-59ACB7C0-FF58-478B-8A6D-3481703CB638Q34180765-D795D0DB-FB97-4293-BDE6-696F6C407285Q34255075-6542D1F1-BDFC-4E5C-8C21-AB46AB7FCB1BQ34750520-6E94F36C-46CF-4253-AE53-DDCB64624C87Q34992760-31D3BD7F-5AF6-41F2-9CB0-7E8575B7B0B5Q35028973-27C17152-C92E-4366-822F-E0E45A7A6018Q35058878-F5D69102-81B0-4169-942A-B91460D47390Q35134417-474067AA-2EB9-438B-AD08-C669294DDE30Q35863787-BF94A4D9-16A6-4E20-82C6-109A2FD6E707Q35883886-000296FB-27B8-43EB-9716-B7FF3417F32FQ35958161-F5B3EFDA-3120-46BD-A647-BBDF09B16B8CQ36189534-0B03281B-5F1C-4FBA-AC24-0286D5E7A1A3Q36337565-5340D806-AD5C-4C83-B0B7-DF66E912669CQ36385224-24034390-B3E0-4D44-B524-CCD8CB73EBE7Q36387512-FE271A42-C0DA-4E99-925D-1043EC9B82DDQ36470602-2AF532B4-F5D2-4814-840E-5107B10A373AQ36554754-E8187574-55B0-410F-9982-218C4C678C32Q36596850-3D6CE4D7-BACF-48A7-ABA8-3660706DCF71Q36682869-945E1699-7E1C-49F2-98DC-197983ED5912Q36753262-88297F36-9118-4E99-9A72-0A3A234818A1Q37466462-DE0E6B2B-D41C-4996-BEFB-B6CF4FAD7125Q37734050-9C3471B1-5525-4019-8EB7-D60AB5396DB1Q37811628-296CDF3C-B04E-4E30-9F57-01F4D64901F2Q38804432-DA182398-E4DA-495E-BBB9-75E0046BE59AQ38823169-D1A73884-1ED0-451C-9EFF-6BBBAC7F8AC0Q38847491-5E31656A-FBD6-4117-BBC6-996531D1C3EEQ38850672-E63B5C13-64E0-4414-93FC-F3E6260006DEQ39002825-3A56846B-E692-4673-9DFA-803F276EEDC9Q39469245-24FFC26F-344E-45C1-8F74-A1B5F0CC518CQ39589473-4B6F968A-D576-4E3B-BF73-E3C858200EFFQ39806047-B485F774-2335-4031-8F30-94BC54723B2AQ40758763-BE91B520-7162-4EE0-87E7-68F51ABD5E2EQ41608002-13C25E45-1F8D-4FA2-A7C1-7AC265892B5A
P2860
Altered levels of cytokines and inflammatory mediators in plasma and leukocytes of sickle cell anemia patients and effects of hydroxyurea therapy.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Altered levels of cytokines an ...... ffects of hydroxyurea therapy.
@en
Altered levels of cytokines an ...... ffects of hydroxyurea therapy.
@nl
type
label
Altered levels of cytokines an ...... ffects of hydroxyurea therapy.
@en
Altered levels of cytokines an ...... ffects of hydroxyurea therapy.
@nl
prefLabel
Altered levels of cytokines an ...... ffects of hydroxyurea therapy.
@en
Altered levels of cytokines an ...... ffects of hydroxyurea therapy.
@nl
P2093
P921
P356
P1476
Altered levels of cytokines an ...... ffects of hydroxyurea therapy.
@en
P2093
C F Franco-Penteado
D M Albuqueque
S T O Saad
P304
P356
10.1189/JLB.0708445
P577
2008-11-12T00:00:00Z